View Exam | PowerPak

1. Which of the following clinical events would meet the American College of Cardiology's (ACC's) definition of a major bleeding event?

A. Drop of hemoglobin from a baseline of 12 g/dL to 11 g/dL B. The need for transfusion of 3 units of packed red blood cells C. An intraluminal gastrointestinal bleed with a blood pressure of 110/50 mmHg and no need for transfusion D. A bleed resulting in a blood pressure decrease to 100/70 mmHg (baseline 110/80 mm/Hg) E. Not sure

2. In a patient taking apixaban, which laboratory assay result would exclude any significant anticoagulant effect from apixaban?

A. Normal prothrombin time (PT) B. Normal international normalized ratio (INR) C. Normal ecarin clotting time (ECT) D. Negative anti-Xa assay calibrated to low molecular weight heparin (LMWH) E. Not sure

3. RB is a 73-year-old male who presents with shortness of breath, hypotension (blood pressure = 80/50 mmHg), and jugular venous distension after a car accident. Evaluation reveals a pericardial tamponade. When reviewing his medications with his wife, she tells you that he is on rivaroxaban 20 mg for his atrial fibrillation, and took his dose about 5 hours ago. What reversal strategy would you recommend for RB to the team?

A. RB does not need a reversal strategy at this time, just supportive care B. Andexanet alfa 800 mg bolus and 960 mg infusion C. Andexanet alfa 400 mg bolus and 480 mg infusion D. 4-factor prothrombin complex concentrate (4F-PCC) at 10 units/kg E. Not sure

4. Which of the following statements about the use of PCCs for the reversal of factor Xa (FXa) inhibitors is true?

A. Fixed dosing of 1500 to 2000 units (U) of 4F-PCC is a potential alternative to weight-based dosing to reverse FXa inhibitors B. 4F-PCC is indicated for the reversal of FXa inhibitors C. PCCs have no prothrombotic effects when used to reverse FXa inhibitors D. The recommended dose for activated PCC (aPCC) is 100 U/kg E. Not sure

5. AJ is a 65-year-old woman who is on apixaban for anticoagulation for her atrial fibrillation. She has recently experienced and been treated for an intracranial hemorrhage (ICH). According to the ACC, how long should you wait before resuming anticoagulation?

A. Anticoagulation should not be restarted for AJ B. 7 days C. 14 days D. 4 weeks E. Not sure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following clinical events would meet the American College of Cardiology's (ACC's) definition of a major bleeding event?

2. In a patient taking apixaban, which laboratory assay result would exclude any significant anticoagulant effect from apixaban?

4. Which of the following statements about the use of PCCs for the reversal of factor Xa (FXa) inhibitors is true?

5. AJ is a 65-year-old woman who is on apixaban for anticoagulation for her atrial fibrillation. She has recently experienced and been treated for an intracranial hemorrhage (ICH). According to the ACC, how long should you wait before resuming anticoagulation?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following clinical events would meet the American College of Cardiology's (ACC's) definition of a major bleeding event?

2. In a patient taking apixaban, which laboratory assay result would exclude any significant anticoagulant effect from apixaban?

4. Which of the following statements about the use of PCCs for the reversal of factor Xa (FXa) inhibitors is true?

5. AJ is a 65-year-old woman who is on apixaban for anticoagulation for her atrial fibrillation. She has recently experienced and been treated for an intracranial hemorrhage (ICH). According to the ACC, how long should you wait before resuming anticoagulation?

« Return to Activity

Customers who Purchased
this Activity also Purchased